StockData
GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31

GoodRx Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.37+0.01 (+0.30%)

Close on Oct 19, 2026

Market cap
$1.17B
P/E (TTM)
84.3
Dividend yield
–

GoodRx Holdings, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
90.8%
Operating margin
9.5%
Net margin
2.1%
Return on equity, FY2025
4.5%

Financial strength

Current ratio
1.38
Debt to equity
0.75
Debt to assets
20.8%
Cash to current liabilities
25.6%

Valuation

P/E ratio
84.3
Price to sales
1.49
Price to book
1.81
Dividend yield
–